Pliant Therapeutics Inc. (PLRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pliant Therapeutics Inc.

    NASDAQ: PLRX · Real-Time Price · USD
    1.75
    0.12 (7.36%)
    At close: Sep 05, 2025, 11:39 AM

    Pliant Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 1.58M 9.69M 7.57M
    Cost of Revenue
    		 2.13M n/a 3.68M 3.2M
    Gross Profit
    		 -2.13M 1.58M 9.69M 7.57M
    Operating Income
    		 -228.37M -184.15M -127.2M -97.53M
    Interest Income
    		 n/a 24.08M 4.67M 272K
    Pretax Income
    		 -210.3M -161.34M -123.32M -97.26M
    Net Income
    		 -210.3M -161.34M -123.32M -97.26M
    Selling & General & Admin
    		 59.05M 57.93M 39.95M 27.56M
    Research & Development
    		 169.31M 127.8M 96.94M 77.55M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 228.37M 185.72M 136.88M 105.11M
    Interest Expense
    		 3.02M 1.27M 791K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 228.37M 185.72M 136.88M 105.11M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 60.54M 58.72M 42.02M 35.85M
    Shares Outstanding (Diluted)
    		 60.54M 58.72M 42.02M 35.85M
    EPS (Basic)
    		 -3.47 -2.75 -2.94 -2.71
    EPS (Diluted)
    		 -3.47 -2.75 -2.94 -2.71
    EBITDA
    		 -228.37M -158.23M -118.85M -95.73M
    EBIT
    		 -189.22M -160.07M -122.53M -97.26M
    Depreciation & Amortization
    		 -39.15M 1.84M 3.68M 1.53M

    Add to Watchlist